5-羟基戊醛 | 4221-03-8

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪醛（含缩醛，半缩醛）
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 5-羟基戊醛
• 英文名称: 5-hydroxypentanal
• 英文别名: 5-hydroxyvaleraldehyde
• CAS: 4221-03-8
• 化学式: C₅H₁₀O₂
• mdl: MFCD00044411
• 分子量: 102.133
• InChiKey: CNRGMQRNYAIBTN-UHFFFAOYSA-N

物化性质

• 沸点：
  131.45°C (rough estimate)
• 密度：
  1.0500
• 溶解度：
  氯仿（微溶）、甲醇（微溶）
• LogP：
  -0.600 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  7
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  3
• 安全说明：
  S24/25
• 海关编码：
  2912491000
• 包装等级：
  II
• 危险类别：
  3,8
• 危险性防范说明：
  P210,P280,P305+P351+P338,P310
• 危险品运输编号：
  2924
• 危险性描述：
  H225,H315,H318,H412
• 储存条件：
  2-8°C

SDS

Name:	5-Hydroxypentanal Tech. Material Safety Data Sheet
Synonym:	5-Hydroxyvaleraldehyd
CAS:	4221-03-8

Section 1 - Chemical Product MSDS Name:5-Hydroxypentanal Tech. Material Safety Data Sheet
Synonym:5-Hydroxyvaleraldehyd

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4221-03-8	5-Hydroxypentanal	100	224-165-5

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode in the heat of a fire. Vapors may be heavier than air.
They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire. Cool containers with flooding quantities of water until well after fire is out.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 4221-03-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions. Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149.
Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 115 deg C @ 15.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0550g/cm3
Molecular Formula: C5H10O2
Molecular Weight: 102.13

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4221-03-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Hydroxypentanal - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4221-03-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4221-03-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4221-03-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-羟基戊醛 在 potassium permanganate 、 硫酸 、 氢溴酸 、 sodium carbonate 作用下， 生成 5-溴戊酸
  参考文献：
  名称：

  Gaudry; Berlinguet, Canadian Journal of Research, Section B: Chemical Sciences, 1949, vol. 27, p. 287

  摘要：

  DOI：
• 作为产物：
  描述：

  1,5-戊二醇 在 溶剂黄146 、 bromamine B 作用下， 以 水 为溶剂， 生成 5-羟基戊醛
  参考文献：
  名称：

  N-溴苯磺酰胺钠氧化二醇的动力学研究

  摘要：

  研究了五种邻二醇，四种其他二醇及其单醚之一被N-溴苯磺酰胺钠氧化的动力学。邻位二醇产生由二元醇键裂变产生的产物，而其他二醇产生羟基羰基化合物。对于二醇和氧化剂，反应是一级的。邻二醇的氧化遵循两种机理途径，一种是非酸依赖性的，另一种是酸依赖性的。其他二醇的氧化显示出对氢离子的一级依赖性。[1,1,2,2- 2 H 4 ]乙二醇的氧化显示不存在主要的动力学同位素效应。溶剂同位素效应的值k（H 2 O）/ k（D2 O），在303 K氧化乙二醇时，丙烷1，，3-二醇和3-甲氧基丁烷-1-醇分别为2.24、0.42和0.42。对于邻二元醇，已经提出了涉及二醇键裂变的无环机理。其他二醇与一元醇一样，通过氢化物转移机理被氧化。

  DOI：

  10.1039/p29870001645

文献信息

• Three-component reductive alkylation of 2-hydroxy-1,4-naphthoquinones with lactols
  作者：Eliana E. Kim、Evans O. Onyango、Jennifer R. Pace、Timothy M. Abbot、Liangfeng Fu、Gordon W. Gribble

  DOI：10.1016/j.tetlet.2016.01.036

  日期：2016.2

  Lactols II, obtained by DIBAL reduction of their corresponding lactones I, in equilibrium with their hydroxyaldehyde tautomers III were used in a three-component reductive alkylation with 2-hydroxy-1,4-naphthoquinone to give a series of 3-alkylated 2-hydroxy-1,4-naphthoquinone derivatives IV.

  通过DIBAL还原相应的内酯I并与羟醛互变异构体III平衡获得的Lactols II与2-羟基-1,4-萘醌进行三组分还原烷基化反应，得到一系列3-烷基化的2-羟基-1，4-萘醌衍生物IV。
• One-Pot Synthesis of Functionalized Nitrones from Nitro Compounds
  作者：Valérie Gautheron-Chapoulaud、Shashi U. Pandya、Pascale Cividino、Géraldine Masson、Sandrine Py、Yannick Vallée

  DOI：10.1055/s-2001-16042

  日期：——

  The zinc-mediated reduction of nitroalkanes and nitroarenes in the presence of aldehydes is an efficient method to synthesize a wide range of nitrones. This method is mild enough to accommodate a variety of functional groups. It is particularly useful when the intermediate hydroxylamines are unstable and/or water-soluble. We used it to prepare several aromatic, aliphatic and highly functionalized sugar-derived nitrones.

  在醛的存在下，锌介导的硝基烷烃和硝基芳烃的还原是一种高效合成多种硝酮的方法。该方法足够温和，能适应各种官能团。当中间体羟胺不稳定和/或水溶性时，这种方法尤为有用。我们利用它制备了多种芳香族、脂肪族和高功能化的糖衍生物硝酮。
• Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib
  作者：Yong-Tao Li、Jing-Han Wang、Cheng-Wen Pan、Fan-Fei Meng、Xiao-Qian Chu、Ya-hui Ding、Wen-Zheng Qu、Hui-ying Li、Cheng Yang、Quan Zhang、Cui-Gai Bai、Yue Chen

  DOI：10.1016/j.bmcl.2016.01.068

  日期：2016.3

  Three novel series of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib were prepared and evaluated in vitro for their cytostatic effects against a human chronic myeloid leukemia (K562), acute myeloid leukemia (HL60), and human leukemia stem-like cell line (KG1a). The structure–activity relationship was analyzed by determining the inhibitory rate of each imatinib analog. Benzene and piperazine

  制备了伊马替尼的三个新系列的1,2,3-三唑和1,3,4-恶二唑衍生物，并在体外评估了它们对人慢性髓性白血病（K562），急性髓性白血病（HL60）和人白血病干样细胞系（KG1a）。通过确定每种伊马替尼类似物的抑制率来分析结构与活性之间的关系。苯和哌嗪环是这些化合物中维持对K562和HL60细胞系抑制活性所必需的基团。引入三氟甲基基团显着增强了化合物对这两种细胞系的效力。出人意料的是，某些化合物对KG1a细胞显示出显着的抑制活性，而没有抑制常见的白血病细胞系（K562和HL60）。
• A bifunctional ligand enables efficient gold-catalyzed hydroarylation of terminal unactivated propargylic alcohols with heteroareneboronic acids
  作者：Shengrong Liao、Huayan Xu、Liang Xu、Baoxia Liang、Bin Yang、Junfeng Wang、Xuefeng Zhou、Xiuping Lin、Zaigang Luo、Yonghong Liu

  DOI：10.1016/j.tet.2020.131764

  日期：2021.1

  Terminal allylic alcohols are important motifs in natural products, and also key intermediates/precursors in numerous novel reaction transformations. In this study, enabled by a bifunctional ligand featuring a basic amino group, a gold-catalyzed hydroarylation of terminal unactivated propargylic alcohols with heteroareneboronic acids has been first established, and efficiently affords various terminal

  末端烯丙醇是天然产物中的重要基序，也是许多新颖反应转化中的关键中间体/前体。在这项研究中，通过具有碱性氨基的双功能配体，首先建立了末端未活化的炔丙醇与杂芳烃硼酸的金催化加氢芳基化反应，并能在温和的条件下以中等至高收率有效地提供各种末端芳基取代的烯丙基醇。条件。
• Design, Synthesis, and Biological Evaluation of the Combinatorial Library with a New Spirodiketopiperazine Scaffold. Discovery of Novel Potent and Selective Low-Molecular-Weight CCR5 Antagonists
  作者：Hiromu Habashita、Masaya Kokubo、Shin-ichi Hamano、Nobuyuki Hamanaka、Masaaki Toda、Shiro Shibayama、Hideaki Tada、Kenji Sagawa、Daikichi Fukushima、Kenji Maeda、Hiroaki Mitsuya

  DOI：10.1021/jm060051s

  日期：2006.7.1

  anti-HIV activity. Herein, we describe in detail the identification of these lead compounds using a combinatorial chemistry approach. A novel spirodiketopiperazine scaffold was designed on the basis of the concept of the privileged structure of G-protein-coupled receptors (GPCRs). This new framework was obtained in acceptable yield with high purity from the readily prepared isonitrile resin through

  我们之前曾报道发现有几种螺二酮哌啶衍生物作为具有抗HIV活性的有效CCR5拮抗剂。在本文中，我们详细描述了使用组合化学方法鉴定这些先导化合物的方法。基于G蛋白偶联受体（GPCR）的优先结构的概念，设计了一种新型的螺二酮哌嗪骨架。通过Ugi反应，顺序转化和环化裂解，可以从容易制备的异腈树脂中以高收率获得可接受的高纯度新骨架。通过测量初始文库中每种化合物对MIP-1alpha刺激的细胞内钙动员的抑制活性，发现了几种化合物显示出适度但有选择性的CCR5拮抗活性。